ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664161 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664161; 2) Community: the network communities that were significantly associated with the response to NSC 664161; 3) Molecule: the relationships between components within communities and NSC 664161; 4) MDR: the compounds that were significantly associated with the NSC 664161.

NSC Compound Enrichment Correlation
NSC 715643 Null 0.00418964244951812 0.65117948
NSC 7364 Metoprine(USAN) 0.00418964244951812 0.043491012
NSC 226080 Sirolimus 0.00587884296262138 0.0065018104
NSC 663790 Null 0.00587884296262138 0.24938074
NSC 682561 Cardenolide 2 0.00587884296262138 0.4920183
NSC 716040 Null 0.00587884296262138 0.2058721
NSC 745098 21-[2-(N,N-dimethylamino)ethyl]-oxy-.7.alpha.-methyl-19-norpregna-1,3,5(10),17(20)-tetraen-3-ol citrate salt 0.00587884296262138 0.58634077
NSC 667707 Null 0.00592008956008459 0.094031898
NSC 683558 Camptothecin Derivative 0.00592008956008459 0.21598333
NSC 696662 (6R,6S)-2,4-Diamino-6-(2,5-dimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline 0.00592008956008459 0.22400492
Total:48  Current:7    [First] [Prev] [Next] [Last]